This inventor holds 2 USPTO granted patents. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Tetsu Kawano: Innovator in NKT Cell-Activating Agents
Introduction
Tetsu Kawano is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of immunology, particularly in the development of NKT cell-activating agents. With a total of 2 patents, his work focuses on therapeutic agents for autoimmune diseases.
Latest Patents
Kawano's latest patents include innovative medicinal compositions that utilize α-glycosylceramides. These compositions aim to provide NKT cell-activating agents that serve as therapeutic solutions for various autoimmune diseases, such as systemic lupus erythematosus, systemic sclerosis, ulcerative colitis, encephalomyelitis, multiple sclerosis, and human type I diabetes. The patents detail the use of α-glycosylceramides, or their salts and solvates, as active ingredients in these compositions.
Career Highlights
Tetsu Kawano is currently associated with Kirin Beer Kabushiki Kaisha, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating complex autoimmune conditions.
Collaborations
Kawano collaborates with notable colleagues, including Masaru Taniguchi and Yasuhiko Koezuka. Their combined expertise contributes to the innovative research being conducted in the field of immunology.
Conclusion
Tetsu Kawano's contributions to the development of NKT cell-activating agents highlight his role as a key innovator in the medical field. His work promises to advance therapeutic options for patients suffering from autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile